BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 11995364)

  • 1. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
    Zaragoza A; Llorente MJ; García MM; Ramírez JJ; Lloret G; Machancoses A
    Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of inhibition OF COX-2 and COX-3 in gastrointestinal damage induced by NSAID in rats ].
    Laudanno OM; San Miguel P; Aramberry LJ; Cesolari JA
    Acta Gastroenterol Latinoam; 2003; 33(4):183-5. PubMed ID: 14708469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2 selectivity in gastroenterology].
    Ledro Cano D; Gómez Rodríguez BJ; Torres Domínguez Y; Hergueta Delgado P; Herrerías Esteban JM; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 1999 Apr; 91(4):305-9. PubMed ID: 10348929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Questions to Professor Jean-François Bretagne].
    Bretagne JF
    Gastroenterol Clin Biol; 2003 May; 27(5):518-21. PubMed ID: 12843914
    [No Abstract]   [Full Text] [Related]  

  • 5. COX 2 inhibitors may increase risk of heart attack.
    Gottlieb S
    BMJ; 2001 Sep; 323(7311):471. PubMed ID: 11532833
    [No Abstract]   [Full Text] [Related]  

  • 6. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
    Bannwarth B
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
    Pronai L; Hritz I; Molnar B; Herszenyi L; Tulassay Z
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):23-30. PubMed ID: 14552701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forthcoming non-steroidal anti-inflammatory drugs: are they really devoid of side effects?
    Bjarnason I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S27-36. PubMed ID: 10379467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The coxibs, selective inhibitors of cyclooxygenase-2.
    Rich SA
    N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
    [No Abstract]   [Full Text] [Related]  

  • 13. [COX-2 specific inhibitors are similar--and different].
    Aly A
    Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
    [No Abstract]   [Full Text] [Related]  

  • 14. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
    Feldman M; McMahon AT
    Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dyspepsia and non-steroidal anti-inflammatory agents: not everything is an ulcer].
    Lanas A; Arroyo MT
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():25-30. PubMed ID: 11968331
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
    Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclooxygenase-2 inhibitors: promise or peril?
    Mengle-Gaw LJ; Schwartz BD
    Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Palmer RH
    JAMA; 2000 Apr; 283(15):1961-2. PubMed ID: 10789662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.